These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10036944)

  • 1. [Investigation about usefulness of serum antibody of Helicobacter pylori and serum pepsinogen I/II ratio as a marker of the judgment after eradication therapy].
    Fujisawa T; Kumagai T; Goto A; Fujimori K; Akamatsu T; Kiyosawa K
    Nihon Rinsho; 1999 Jan; 57(1):101-6. PubMed ID: 10036944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication.
    Masaoka T; Suzuki H; Imaeda H; Hosoda H; Ohara T; Morishita T; Ishii H; Kangawa K; Hibi T
    Hepatogastroenterology; 2005; 52(61):1-4. PubMed ID: 15782980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of serological IgG antibody determinations for confirming eradication of Helicobacter pylori infection.
    Marchildon P; Balaban DH; Sue M; Charles C; Doobay R; Passaretti N; Peacock J; Marshall BJ; Peura DA
    Am J Gastroenterol; 1999 Aug; 94(8):2105-8. PubMed ID: 10445535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
    Leja M; Lapina S; Polaka I; Rudzite D; Vilkoite I; Daugule I; Belkovets A; Pimanov S; Makarenko J; Tolmanis I; Lejnieks A; Boka V; Rumba-Rozenfelde I; Vikmanis U
    Medicina (Kaunas); 2014; 50(1):8-13. PubMed ID: 25060199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum pepsinogens as an early diagnostic marker of H. pylori eradication.
    Shirai N; Furuta T; Sugimoto M; Kanaoka S; Watanabe F; Takashima M; Yamada M; Futami H; Sato Y; Kubota H; Kodaira M; Kajimura M; Maekawa M; Hishida A
    Hepatogastroenterology; 2008; 55(82-83):486-90. PubMed ID: 18613393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between serum pepsinogen A and C levels, serum gastrin concentrations and Helicobacter pylori antibodies.
    Kullich W; Pöllmann G; Czerwenka C; Klein G
    Wien Med Wochenschr; 1999; 149(7):157-61. PubMed ID: 10413837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.
    Haneda M; Kato M; Ishigaki S; Suzuki M; Takahashi M; Nakagawa M; Ono S; Mori Y; Mabe K; Nakagawa S; Kudo T; Shimizu Y; Asaka M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):78-83. PubMed ID: 23034090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and laboratory evaluation of efficiency of Helicobacter pylori eradication].
    Drygina LB; Poiarkova NA; Sablin OA
    Eksp Klin Gastroenterol; 2010; (2):27-31. PubMed ID: 20496805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
    Rosengren H; Polson RJ
    Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.
    Osumi H; Fujisaki J; Suganuma T; Horiuchi Y; Omae M; Yoshio T; Ishiyama A; Tsuchida T; Miki K
    PLoS One; 2017; 12(8):e0183980. PubMed ID: 28854276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of Helicobacter pylori serology after successful eradication.
    Cutler AF; Prasad VM
    Am J Gastroenterol; 1996 Jan; 91(1):85-8. PubMed ID: 8561150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Time course changes in morphological and functional characteristics of gastric mucosa after eradication of Helicobacter pylori in duodenal ulcers].
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME
    Ter Arkh; 2006; 78(2):26-31. PubMed ID: 16613092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection.
    Di Mario F; Moussa AM; Cavallaro LG; Caruana P; Merli R; Bertolini S; Iori V; Cavestro GM; Dal Bò N; Pilotto A; Franzé A; Leandro G
    Digestion; 2004; 70(3):167-72. PubMed ID: 15479977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
    Gisbert JP; Boixeda D; Vila T; de Rafael L; Alvarez Baleriola I; Martín de Argila C
    Med Clin (Barc); 1995 Nov; 105(15):561-5. PubMed ID: 7500674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura.
    Kodama M; Kitadai Y; Ito M; Kai H; Masuda H; Tanaka S; Yoshihara M; Fujimura K; Chayama K
    Helicobacter; 2007 Feb; 12(1):36-42. PubMed ID: 17241299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.